Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA

Mise à jour : Il y a 4 ans
Référence : NCT02348619

Femme et Homme

Extrait

This trial is a 6-week, double-blind, placebo-controlled, randomized-withdrawal, multicenter study of safety and efficacy of JZP-110 in the treatment of excessive sleepiness in adult subjects with OSA.


Critère d'inclusion

  • Obstructive Sleep Apnea


Liens